According to a statement by the company AstraZeneca and Health Technology Company Qure. In this way, 50,000 people were aimed at advanced examinations and diagnostic centers, and early diagnosis was made available. In Turkiye, artificial intelligence -supported screening of around 200,000 lung graphs were completed in three important centers in Türkiye.
Lung cancer, one of the most deaths that led to death worldwide, made more than 1.8 million people die in 2022.
More than 50 percent of cases are diagnosed in advanced stages, while the five -year survival rate of these patients remains below 10 percent. In cases that were identified in the early stage, the survival rate can vary between 68 and 92 percent.
In addition, approximately 70 percent of deaths are observed due to lung cancer in low and medium -sized countries in which lung cancer can normally be recognized more restricted.
“We have revealed our provision for early diagnosis”
Ti Hwei How, Vice President International Oncology, said in cooperation with the international oncology of Astrazeneca.
How to work with the support of the support of artificial intelligence for lung radios can be used as a inexpensive instrument to recognize lung cancer: “We successfully take this method to achieve global distribution steps.
Bir yanıt yazın